Genetics of Pediatric Epilepsy

Pediatric Clinics of North America

Volumn 62, Issue 3, 2015, Pages 703-722

  Hani, Abeer J ^a   Mikati, Husam M ^b   Mikati, Mohamad A ^a  

^a DUKE CHILDREN S HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Epilepsy; Epilepsy syndromes; Genetics

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PHOSPHOLIPASE C BETA1; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNT1; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT;

ACCURACY; AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY; AUTOSOMAL DOMINANT PARTIAL EPILEPSY WITH AUDITORY FEATURE; BENIGN EPILEPSY WITH CENTROTEMPORAL SPIKE; BENIGN FAMILIAL INFANTILE SEIZURE; BENIGN FAMILIAL NEONATAL INFANTILE SEIZURE; BENIGN FAMILIAL NEONATAL SEIZURE; BENIGN MYOCLONIC EPILEPSY OF INFANCY; CHILDHOOD ABSENCE EPILEPSY; EPILEPSY; EPILEPSY OF INFANCY WITH MIGRATING FOCAL SEIZURE; EPILEPSY WITH MYOCLONIC ATONIC SEIZURE; EPILEPTIC ENCEPHALOPATHY WITH CONTINUOUS SPIKE AND WAVE DURING SLEEP; FAMILIAL FOCAL EPILEPSY WITH VARIABLE FOCI; FAMILIAL INFANTILE MYOCLONIC EPILEPSY; GAIN OF FUNCTION MUTATION; GENE; GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS; GENETIC ASSOCIATION; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANTILE SPASM; ION CHANNEL GENE; LANDAU KLEFFNER SYNDROME; LENNOX GASTAUT SYNDROME; LOSS OF FUNCTION MUTATION; MUTATIONAL ANALYSIS; MYOCLONUS EPILEPSY; NEONATAL EPILEPTIC ENCEPHALOPATHY; NEUROTRANSMITTER RECEPTOR GENE; NONHUMAN; ONSET AGE; PANAYIOTOPOULOS SYNDROME; PEDIATRIC EPILEPSY; PERSONALIZED MEDICINE; PHENOTYPE; REFLEX EPILEPSY; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SIGNAL TRANSDUCTION; STRUCTURAL GENE; SYNDROMIC GENETIC EPILEPSY; ADOLESCENT; CHILD; GENOTYPE; INFANT; MUTATION; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; EPILEPSY; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MUTATION; PHENOTYPE;

EID: 84929919483     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2015.03.013     Document Type: Review

References (82)

1. Mefford H.C. CNVs in epilepsy. Curr Genet Med Rep 2014, 2:162-167.
2. Choueiri R.N., Fayad M.N., Farah A., et al. Classification of epilepsy syndromes and role of genetic factors. Pediatr Neurol 2001, 24(1):37-43.
3. Peljto A.L., Barker-Cummings C., Vasoli V.M., et al. Familial risk of epilepsy: a population-based study. Brain 2014, 137(Pt 3):795-805.
4. Guerrini R., Noebels J. How can advances in epilepsy genetics lead to better treatments and cures?. Adv Exp Med Biol 2014, 813:309-317.
5. Winawer M.R., Shinnar S. Genetic epidemiology of epilepsy or what do we tell families?. Epilepsia 2005, 46(Suppl 10):24-30.
6. Berkovic S.F., Howell R.A., Hay D.A., et al. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998, 43(4):435-445.
7. Thomas R.H., Berkovic S.F. The hidden genetics of epilepsy-a clinically important new paradigm. Nat Rev Neurol 2014, 10(5):283-292.
8. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
9. Scheffer I.E. Epilepsy genetics revolutionizes clinical practice. Neuropediatrics 2014, 45(2):70-74.
10. Tripathi M., Jain S. Genetics in epilepsy: transcultural perspectives. Epilepsia 2003, 44(Suppl 1):12-16.
11. Novarino G., Baek S.T., Gleeson J.G. The sacred disease: the puzzling genetics of epileptic disorders. Neuron 2013, 80(1):9-11.
12. EPGP Collaborative, Abou-Khalil B., Alldredge B., et al. The epilepsy phenome/genome project. Clin Trials 2013, 10(4):568-586.
13. Epi K.C. Epi4K: gene discovery in 4,000 genomes. Epilepsia 2012, 53(8):1457-1467.
14. Hildebrand M.S., Dahl H.H., Damiano J.A., et al. Recent advances in the molecular genetics of epilepsy. J Med Genet 2013, 50(5):271-279.
15. Online Mendelian Inheritance in Man (OMIM). Available at: . Accessed September 1, 2014. http://www.ncbi.nlm.nih.gov/omim/.
16. Kearney J.A., Yang Y., Beyer B., et al. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Hum Mol Genet 2006, 15(6):1043-1048.
17. Glasscock E., Qian J., Yoo J.W., et al. Masking epilepsy by combining two epilepsy genes. Nat Neurosci 2007, 10(12):1554-1558.
18. McKhann G.M., Wenzel H.J., Robbins C.A., et al. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 2003, 122(2):551-561.
19. Papandrea D., Anderson T.M., Herron B.J., et al. Dissociation of seizure traits in inbred strains of mice using the flurothyl kindling model of epileptogenesis. Exp Neurol 2009, 215(1):60-68.
20. Leonard A.S., Hyder S.N., Kolls B.J., et al. Seizure predisposition after perinatal hypoxia: effects of subsequent age and of an epilepsy predisposing gene mutation. Epilepsia 2013, 54(10):1789-1800.
21. Veerapandiyan A., Winchester S.A., Gallentine W.B., et al. Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy. Epilepsy Behav 2011, 20(3):494-501.
22. Naasan G., Yabroudi M., Rahi A., et al. Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations. Epileptic Disord 2009, 11(4):293-300.
23. Mikati M.A., Zalloua P., Karam P., et al. Novel mutation causing partial biotinidase deficiency in a Syrian boy with infantile spasms and retardation. J Child Neurol 2006, 21(11):978-981.
24. Mikati M.A., Trevathan E., Krishnamoorthy K.S., et al. Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalogr Clin Neurophysiol 1991, 78(3):215-221.
25. Steele S.U., Cheah S.M., Veerapandiyan A., et al. Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency. Epilepsy Behav 2012, 24(4):507-512.
26. El-Hajj T.I., Karam P.E., Mikati M.A. Biotin-responsive basal ganglia disease: case report and review of the literature. Neuropediatrics 2008, 39(5):268-271.
27. Ream M.A., Mikati M.A. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav 2014, 37:241-248.
28. Rees M.I. The genetics of epilepsy-the past, the present and future. Seizure 2010, 19(10):680-683.
29. Kullmann D.M. Neurological channelopathies. Annu Rev Neurosci 2010, 33:151-172.
30. Deprez L., Jansen A., De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life. Neurology 2009, 72(3):273-281.
31. Allen N.M., Mannion M., Conroy J., et al. The variable phenotypes of KCNQ-related epilepsy. Epilepsia 2014, 55(9):e99-e105.
32. Maljevic S., Lerche H. Potassium channel genes and benign familial neonatal epilepsy. Prog Brain Res 2014, 213:17-53.
33. Orhan G., Bock M., Schepers D., et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy. Ann Neurol 2014, 75(3):382-394.
34. Berkovic S.F., Heron S.E., Giordano L., et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004, 55(4):550-557.
35. Tavyev Asher Y.J., Scaglia F. Molecular bases and clinical spectrum of early infantile epileptic encephalopathies. Eur J Med Genet 2012, 55(5):299-306.
36. Vigevano F. Benign familial infantile seizures. Brain Dev 2005, 27(3):172-177.
37. Brunklaus A., Zuberi S.M. Dravet syndrome-from epileptic encephalopathy to channelopathy. Epilepsia 2014, 55(7):979-984.
38. Wolff M., Casse-Perrot C., Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006, 47(Suppl 2):45-48.
39. Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68(6):1327-1332.
40. Williams C.A., Battaglia A. Molecular biology of epilepsy genes. Exp Neurol 2013, 244:51-58.
41. Stafstrom C.E. Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations. J Child Neurol 2009, 24(8 Suppl):15S-23S.
42. Lossin C. A catalog of SCN1A variants. Brain Dev 2009, 31(2):114-130.
43. Catterall W.A., Kalume F., Oakley J.C. NaV1.1 channels and epilepsy. J Physiol 2010, 588(Pt 11):1849-1859.
44. Catterall W.A. Sodium channels, inherited epilepsy, and antiepileptic drugs. Annu Rev Pharmacol Toxicol 2014, 54:317-338.
45. Laux L., Blackford R. The ketogenic diet in Dravet syndrome. J Child Neurol 2013, 28(8):1041-1044.
46. Devinsky O., Cilio M.R., Cross H., et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014, 55(6):791-802.
47. Pavone P., Striano P., Falsaperla R., et al. Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013. Brain Dev 2014, 36(9):739-751.
48. Paciorkowski A.R., Thio L.L., Dobyns W.B. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011, 45(6):355-367.
49. Poulat A.L., Lesca G., Sanlaville D., et al. A proposed diagnostic approach for infantile spasms based on a spectrum of variable aetiology. Eur J Paediatr Neurol 2014, 18(2):176-182.
50. Caraballo R.H., Dalla Bernardina B. Idiopathic generalized epilepsies. Handb Clin Neurol 2013, 111:579-589.
51. Coppola G. Malignant migrating partial seizures in infancy. Handb Clin Neurol 2013, 111:605-609.
52. Barcia G., Fleming M.R., Deligniere A., et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012, 44(11):1255-1259.
53. Bearden D., Strong A., Ehnot J., et al. Targeted treatment of migrating partial seizures of infancy with quinidine. Ann Neurol 2014, 76(3):457-461.
54. Mikati MA, Jiang Y, Carboni M, et al. Quinidine in the treatment of KCNT1 positive epilepsies. Ann Neurol; in press.
55. Poduri A., Heinzen E.L., Chitsazzadeh V., et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 2013, 74(6):873-882.
56. Poduri A., Chopra S.S., Neilan E.G., et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 2012, 53(8):e146-e150.
57. Striano P., de Falco F.A., Minetti C., et al. Familial benign nonprogressive myoclonic epilepsies. Epilepsia 2009, 50(Suppl 5):37-40.
58. Vigevano F., Specchio N., Fejerman N. Idiopathic focal epilepsies. Handb Clin Neurol 2013, 111:591-604.
59. Strug L.J., Clarke T., Chiang T., et al. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet 2009, 17(9):1171-1181.
60. Chen Y., Parker W.D., Wang K. The role of T-type calcium channel genes in absence seizures. Front Neurol 2014, 5:45.
61. Hirose S. Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy. Prog Brain Res 2014, 213:55-85.
62. Lesca G., Rudolf G., Bruneau N., et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013, 45(9):1061-1066.
63. Kelley S.A., Kossoff E.H. Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress. Dev Med Child Neurol 2010, 52(11):988-993.
64. Nordli D.R. Epileptic encephalopathies in infants and children. J Clin Neurophysiol 2012, 29(5):420-424.
65. Mann E.O., Mody I. The multifaceted role of inhibition in epilepsy: seizure-genesis through excessive GABAergic inhibition in autosomal dominant nocturnal frontal lobe epilepsy. Curr Opin Neurol 2008, 21(2):155-160.
66. Heron S.E., Smith K.R., Bahlo M., et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012, 44(11):1188-1190.
67. Nobile C., Michelucci R., Andreazza S., et al. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009, 30(4):530-536.
68. Dibbens L.M., de Vries B., Donatello S., et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013, 45(5):546-551.
69. Poduri A. DEPDC5 does it all: shared genetics for diverse epilepsy syndromes. Ann Neurol 2014, 75(5):631-633.
70. Shahwan A., Farrell M., Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005, 4(4):239-248.
71. de Siqueira L.F. Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects. J Neurol 2010, 257(10):1612-1619.
72. Girard J.M., Turnbull J., Ramachandran N., et al. Progressive myoclonus epilepsy. Handb Clin Neurol 2013, 113:1731-1736.
73. Hallmann K., Zsurka G., Moskau-Hartmann S., et al. A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. Neurology 2014, 83(23):2183-2187.
74. Mosbech M.B., Olsen A.S., Neess D., et al. Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy. Ann Clin Transl Neurol 2014, 1(2):88-98.
75. Farhan S.M., Murphy L.M., Robinson J.F., et al. Linkage analysis and exome sequencing identify a novel mutation in KCTD7 in patients with progressive myoclonus epilepsy with ataxia. Epilepsia 2014, 55(9):e106-e111.
76. Franceschetti S., Michelucci R., Canafoglia L., et al. Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology 2014, 82(5):405-411.
77. Boisse Lomax L., Bayly M.A., Hjalgrim H., et al. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Brain 2013, 136(Pt 4):1146-1154.
78. Wolf P., Koepp M. Reflex epilepsies. Handb Clin Neurol 2012, 107:257-276.
79. Lund C., Brodtkorb E., Oye A.M., et al. CHD2 mutations in Lennox-Gastaut syndrome. Epilepsy & behavior: E&B 2014, 33:18-21.
80. Chung S.K., Bode A., Cushion T.D., et al. GLRB is the third major gene of effect in hyperekplexia. Hum Mol Genet 2013, 22(5):927-940.
81. Noh G.J., Jane Tavyev Asher Y., Graham J.M. Clinical review of genetic epileptic encephalopathies. Eur J Med Genet 2012, 55(5):281-298.
82. Crino P.B. mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011, 17(12):734-742.